drugset
drugset / Trial / NCT03011931

Simvastatin Metabolism as a Test for CD Activity (IRB 15-007568]

NCT03011931 ↗

Phase 0 Completed 40 enrolled Entero Therapeutics Immunogenics, LLC · collab
NaSingle-groupOpen-labelDiagnostic

Summary

To study the correlation between simvastatin metabolism by the enterocyte and the histologic state of the intestine in treated celiac disease.

Timeline

Start
2016-03
Primary completion
2019-01
Completion
2019-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Simvastatin Small molecule 20 mg Oral

Indications

celiac disease